GREY:DGCRF - Post by User
Post by
ready2go1on Mar 03, 2011 1:18pm
253 Views
Post# 18226083
Timing
TimingMy timing and predictions have been off for years with CUR; a couple quick thoughts;
its clear that PCA3 will be approved this year but unsure of date; I will take a conservative approach and say around $40 million in revenue 1st year which = $6.4 to Diagnocure; 2nd year $80 million = $12.8 million ; We could argue about the #'s but at some point they will get there and CUR will have the $ to do what they want, for now they are in a wait and hold position.
It should have been done yrs ago, but I think that CUR will close the Philly lab until they find a partner (GCC blood test will be published this yr) but the lab is eating away their cash. I beleive in the test but it is in a very early stage and needs $'s to market and sales reps on the street to push the test.